Inhibition of aldose reductase and Xylose-induced lens opacity by puerariafuran from the roots of Pueraria lobata

Biological and Pharmaceutical Bulletin

Volumn 33, Issue 9, 2010, Pages 1605-1609

  Kim, Nan Hee ^a   Kim, Young Sook ^a   Lee, Yun Mi ^a   Jang, Dae Sik ^a   Kim, Jin Sook ^a  

^a Korea Institute of Oriental Medicine (KIOM)   (South Korea)

Author keywords

Aldose reductase; Lens opacity; Puerariafuran

Indexed keywords

ALDEHYDE REDUCTASE; BENZOFURAN DERIVATIVE; CATALASE; GLUTATHIONE; GLUTATHIONE DISULFIDE; METHANOL; PLANT EXTRACT; PUERARIA LOBATA EXTRACT; PUERARIAFURAN; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG; XYLOSE;

ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CATARACT; CONTROLLED STUDY; DRUG EFFICACY; DRUG ISOLATION; DRUG STRUCTURE; ENZYME ACTIVITY; ENZYME INHIBITION; IC 50; IN VITRO STUDY; INHIBITION KINETICS; NONHUMAN; PLANT ROOT; PUERARIA; PUERARIA LOBATA; RAT;

ALDEHYDE REDUCTASE; ANIMALS; BENZOFURANS; CATARACT; PLANT EXTRACTS; PLANT ROOTS; PUERARIA; RATS; RATS, SPRAGUE-DAWLEY; XYLOSE;

EID: 77957573191     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.33.1605     Document Type: Article

References (28)

1. Brownlee M., Diabetes, 54, 1615-1625 (2005).
2. Anil Kumar P., Bhanuprakash R. G., Exp. Eye Res., 85, 739-740 (2007).
3. Ohta Y., Torri H., Okada H., Hattori H., Majima Y., Ishiguro I., Curr. Eye Res., 15, 1-7 (2006).
4. Collins J. G., Corder Clinton N., Invest. Ophthalmol. Vis. Sci., 16, 242-243 (1977).
5. Hotta N., Toyota T., Matsuoka K., Shigeta Y., Kikkawa R., Kaneko T., Takahashi A., Sugimura K., Koike Y., Ishii J., Sakamoto N., Diabetes Care, 24, 1776-1782 (2001).
6. Kyselova Z., Stefek M., Bauer V., J. Diabetes Complications, 18, 129-140 (2004).
7. Lerner B. C., Varma S. D., Richards R. D., Arch. Ophthalmol., 102, 917-920 (1984).
8. de la Fuente J. A., Manzanaro S., Nat. Prod. Rep., 20, 243-251 (2003).
9. Kinoshita J. H., Dvornik D., Kraml M., Gabbay K. H., Biochim. Biophys. Acta, 158, 472-475 (1968).
10. Obrosova I. G., Minchenko A. G., Vasupuram R., White L., Abatan O. I., Kymagai A. K., Frank R. N., Stevens M. J., Diabetes, 52, 864-871 (2003).
11. Jang D. S., Lee G. Y., Kim Y. S., Lee Y. M., Kim C. S., Yoo J. L., Kim J. S., Biol. Pharm. Bull., 30, 2207-2210 (2007).
12. Kawanishi K., Ueda H., Moriyasu M., Curr. Med. Chem., 10, 1353-1374 (2003).
13. Kim Y. S., Kim N. H., Jung D. H., Sohn E. J., Lee Y. M., Jang D. S., Kim J. S., Diabetes, 57, A114 (2008).
14. Suryanarayana P., Kumar P. A., Saraswat M., Petrash J. M., Reddy G. B., Mol. Vis., 10, 148-154 (2004).
15. Suryanarayana P., Saraswat M., Mrudula T., Krishna T. P., Krishmaswamy K., Redddy G. B., Invest. Ophthalmol. Vis. Sci., 46, 2092-2099 (2005).
16. Giblin F. J., J. Ocul. Pharmacol. Ther., 16, 121-135 (2000).
17. Pirie A., Van Heyningen R., Boag. J. W., Biochem. J., 54, 682-688 (1953).
18. Obrosova I. G., Van Huysen C., Fathallah L., Cao X. C., Greene D. A., Stevens M. J., FASEB J., 16, 123-125 (2002).
19. Altomare E., Grattagliano I., Vendemaile G., Micelli-Ferrari T., Signorile A., Cardia L., Eur. J. Clin. Invest., 27, 141-147 (2007).
20. Jang D. S., Kim J. M., Lee Y. M., Kim Y. S., Kim J. M., Kim J. S., Chem. Pharm. Bull., 54, 1315-1317 (2006).
21. Kamboj V. P., Indian J. Med. Res., 87, 336-355 (1988).
22. Lin R. C., Li T. K., Am. J. Clin. Nutr., 68, 1512S-1515S (1998).
23. Chung Y. S., Choi Y. H., Lee S. J., Choi S. A., J. Ethnopharmacol., 101, 49-54 (2005).
24. Dufrane S. P., Malaisse W. J., Sener A., Biochem. Med., 32, 99-105 (1984).
25. Kim Y. S., Kim N. H., Jung D. H., Lee Y. M., Kim J. M., Kim J. S., Eur. J. Pharmacol., 594, 18-25 (2008).
26. Kim Y. S., Kim N. H., Lee S. W., Lee Y. M., Jang D. S., Kim J. S., Eur. J. Pharmacol., 569, 171-179 (2007).
27. Rhone M., Basu A., Nutr. Rev., 66, 465-472 (2008).
28. Nakamura J., Kasuya Y., Hamada Y., Nakashima E., Naruse K., Yasuda Y., Kato K., Hotta N., Diabetologia, 44, 480-487 (2001).